Skip to content
Dr Paul Shore's Research and Teaching

Dr Paul Shore's Research and Teaching

Gene expression and human disease

  • Welcome
  • Publications
  • Research
  • People
  • NEWS
  • Vacancies
  • PhD students
  • Contact
  • Supplementary data
Search Search Close
  • Home
  • 2014
  • September
  • 12
  • Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer

Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer

September 12, 2014 admin

Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer.

Post navigation

Previous Previous post: Repression of Transcription by WT1-BASP1 Requires the Myristoylation of BASP1 and the PIP2-Dependent Recruitment of Histone Deacetylase

Shore Laboratory – Manchester University

Our latest research paper published in the Nature journal, Oncogene (Impact Factor 7.971). Ran, R., Harrison, H., Syamimi Ariffin, N. et al. A role for CBFβ in maintaining the metastatic phenotype of breast cancer cells. Oncogene 39, 2624–2637 (2020).

  • Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer
  • Repression of Transcription by WT1-BASP1 Requires the Myristoylation of BASP1 and the PIP2-Dependent Recruitment of Histone Deacetylase
  • Find A PhD Project: The molecular basis of metastatic Breast Cancer at University of Manchester
  • Cytoskeletal protein filamin A is a nucleolar protein that suppresses ribosomal RNA gene transcription. – F1000Prime
  • Welcome
  • Publications
  • Research
  • People
  • NEWS
  • Vacancies
  • PhD students
  • Contact
  • Supplementary data
Copyright © All rights reserved.
Education Soul by WEN Themes